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Rapid development in the field of nanomedicine is bringing novel opportunities for improved disease diagnosis and drug delivery. 
Among various nanomaterials involved in nanomedicine, carbon nanotubes (CNTs) possessing a unique one-dimensional struc-
ture with interesting intrinsic mechanical, physical, and chemical properties have been extensively explored for a wide range of 
applications in biology and medicine. This review article provides an overview of how CNTs are used in different aspects of bio-
medicine including drug delivery and cancer treatment, bio-sensing, biomedical imaging, as well as tissue engineering. The recent 
developments, future perspective, and major challenges in this field are discussed. 
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Since Iijima first discovered carbon nanotubes (CNTs) in 
1991 [1], intensive investigations of their structures and 
properties have been actively pursued for potential applica-
tions in various fields [2–7]. Carbon nanotubes are catego-
rized into two structural forms, including single-walled 
carbon nanotubes (SWNTs) and multi-walled nanotubes 
(MWNTs), both of which have shown great application in 
many areas including composite materials, nanoelectronics, 
field effect emitters, energy research, as well as biomedicine 
[7–10]. 
Motivated by the unique one-dimensional (1-D) structure, 
and interesting physical and chemical properties, CNTs 
have been extensively explored in the field of biology and 
medicine. In this paper, we will provide an overview of the 
biomedical applications of CNTs in different applications, 
including drug delivery, cancer treatment, biosensors, bio-
medical imaging, and as composite materials for tissue en-
gineering. CNT-based drug delivery has shown promise for 
the intracellular delivery of small drug molecules, DNA 
plasmids, short-interfering RNA (siRNA), and proteins, for 
applications in disease treatment such as cancer therapies in 
vitro and in vivo [11–17]. The unique optical and electrical 
properties of CNTs make them attractive platforms to detect 
various biological molecules [18,19]. SWNTs exhibit many 
intrinsic optical properties such as optical absorption and 
photoluminescence in the near-infrared region (NIR), as 
well as strong resonance Raman scattering, all of which can 
be used in different biological imaging modalities [20–22]. 
Moreover, CNTs with excellent mechanical properties have 
also found applications as potential tissue engineering scaf-
fold materials [23,24]. CNT-based nanomaterials appear to 
be encouraging and may bring novel opportunities for future 
disease diagnosis and treatment (Table 1).  
1  Drug delivery and cancer treatment  
Functionalized CNTs are able to enter cells without obvious 
toxicity [11,12], and are able to shuttle small drug molecules 
and biological macromolecules, including plasmids, siRNA, 
and proteins into cells [13–17]. CNT-based drug delivery 
has not only been experimentally demonstrated at the cellu-
lar level, but also applied for the treatment of cancer in an-
imal models [15,17,25,28,31]. The physical properties,  
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Table 1  A summary of the use of carbon nanotubes for various biomedical applications 
Applications Examples 
Drug delivery and cancer 
treatment 
Delivery of small drug molecules Covalently conjugated to CNTs (e.g. Pt (IV) pro-drug, paclitaxel) [25–27] 
Non-covalently conjugated to CNTs (e.g. doxorubicin) [15,17] 
Gene delivery Plasmid DNA and siRNA [13,16,28–34] 
Delivery of proteins Proteins covalently or noncovalently conjugated to CNTs [12,14] 
Physical cancer therapies delivered by CNTs Photothermal therapy [35–42] 
Radiofrequency (RF)-induced cancer ablation [43] 
Biosensing Optical sensors NIR fluorescence biosensors (e.g. sensing of β-D-glucose, the conformational poly-
morphism of DNA, etc.) [20,44–48] 
Raman and SERS biosensors (e.g. protein detection) [49] 
Electronic and electrochemical sensors Electronic biosensors (e.g. NH3, NO2, proteins, DNA, etc.) [50–55] 
Electrochemical biosensors (e.g. DNA, viruses, antigens, etc.) [56–61] 
Biomedical imaging NIR fluorescence imaging (drosophila larvae, cells, etc.) [22,62–65] 
Raman imaging (targeted in vivo and multicolor imaging) [20,21,66,67] 
Photoacoustic imaging in mice [68,69] 
Scaffolds in tissue engineering CNTs as scaffolds in bone regeneration [70–73] 
CNTs for neural applications [61,74,75] 
 
especially the optical properties, have also been utilized for 
novel cancer therapies [35–43]. 
1.1  Delivery of small molecules 
Small drug molecules may be loaded on CNTs via either 
covalent conjugation or non-covalent adsorption for drug 
delivery. Small anti-cancer drug molecules are able to be 
covalently conjugated to nanotubes. CNTs are covalently 
functionalized via the 1,3-dipolar cycloaddition of azome-
thine ylides containing amino groups that could be used to 
conjugate with drugs and/or fluorescent probes [27,76]. 
Furthermore, Dhar et al. [26] reported that the Pt (IV) 
pro-drug could be delivered into cells by SWNTs but was 
reduced to a cytotoxic Pt (II) compound after endocytosis 
resulting in cancer cell destruction.  
SWNT-based in vivo drug delivery for cancer treatment 
in animal experiments was first reported by Liu et al. [25] in 
2008. In this work, paclitaxel (PTX) was conjugated to 
branched polyethylene glycol (PEG) chains on SWNTs via 
a cleavable ester bond (Figure 1(a) and (c)). The blood cir-
culation time of the SWNT-PTX complex was found to be 
much longer than that of free PTX, resulting in increased 
drug accumulation in the tumor due to the enhanced per-
meability and retention (EPR) effect of cancerous tumors, 
and thus, improved the therapeutic efficacy for the delay of 
tumor growth. Wu et al. [27] demonstrated that it was pos-
sible for MWNTs to be covalently conjugated to the anti-
tumor agent, 10-hydroxycamptothecin (HCPT), using hy-
drophilic diaminotriethylene glycol as the spacer. The re-
sulting MWNT-HCPT conjugates were found to be superior 
in antitumor activity both in vitro and in vivo compared with 
the clinical HCPT formulation. In vivo tumor targeted drug 
delivery with CNTs was also reported by Bhirde et al. [77]. 
In their work, SWNTs were co-conjugated with cisplatin 
and epidermal growth factor (EGF) to specifically target 
squamous cancer cells for in vivo treatment. The targeted 
SWNT-cisplatin-EGF conjugate exhibited improved tumor 
growth inhibition effect to the EGF receptor (EGFR) posi-
tive head and neck squamous cell carcinoma (HNSCC) tu-
mors, owing to specific EGF-EGFR binding which enhanced 
the uptake of nanotube-delivered drugs in tumors. 
Apart from covalent linking, aromatic anti-cancer mole-
cules, such as doxorubicin (DOX), can robustly bind to the 
side walls of CNTs via non-covalent - stacking (Figure 
1(a) and (b)); drug binding and release could be controlled 
by varying the pH [15]. The loading capacity of DOX on 
PEGylated SWNTs was shown to be as high as 400% by 
weight, owing to the ultra-high surface area of nanotubes 
compared other conventional drug nanocarriers. In a later 
study, the SWNT-DOX complex was further utilized for in 
vivo cancer treatment (Figure 1(d)) [17]. It was found that 
although the treatment efficacy of SWNT-DOX was only 
slightly higher than that of free DOX at the same drug dose, 
where SWNT-DOX exhibited remarkably reduced toxic 
effect to the treated animals, and was safe in mice, even at 
twice the drug dose (Figure 1(e) and (f)). 
1.2  Gene delivery  
Unlike small drug molecules which can enter cells by diffu-
sion, biomacromolecules including DNA, RNA, and protein, 
are not able to penetrate the cell membrane and therefore 
require delivery vehicles for intracellular delivery. Pantarotto  
 Wang X J, et al.   Chin Sci Bull   January (2012) Vol.57 No.2-3 169 
 
Figure 1  (Color online) Drug delivery with SWNTs. (a) A scheme showing non-covalent supramolecular - stacking of doxorubicin and covalent conju-
gation of paclitaxel on PEGylated SWNTs; UV-VIS-NIR spectra of DOX loaded SWNT (b) and PTX conjugated SWNT (c) solutions. Inset: photos of the 
corresponding solutions; Raji tumor bearing severe combined immune deficient (SCID) mice were treated with different DOX formulations once per week at 
day 0 and day 7. (d) Tumor sizes of untreated, 5 mg/kg free DOX treated, 5 mg/kg DOX treated, 5 mg/kg SWNT-DOX treated and 10 mg/kg SWNT-DOX 
treated mice were measured during treatment. Mean tumor volume was normalized to day 0. (e) SWNT-DOX resulted in far less weight loss than DOX and 
DOXIL. Mean body weight was normalized to day 0. (f) Kaplan-Meier analysis. P-values: DOX 5 mg/kg vs. SWNT-DOX 5 or 10 mg/kg, P<0.001; DOXIL 
5 mg/kg vs. SWNT-DOX 5 mg/kg, P=0.013; DOXIL 5 mg/kg vs. SWNT-DOX 10 mg/kg, P<0.001. Error bars in (b) and (c) were based on the standard 
error of the mean (SEM) [15,17,25].  
et al. [28] successfully delivered plasmid DNA into mam-
malian HeLa cells by using ammonium-functionalized CNTs 
with positive charges, although the efficiency was not satis-
factory; plasmid DNA was loaded onto CNTs through elec-
trostatic interactions. To improve the transfection efficiency 
of CNTs, cationic polymers including polyethylenimine 
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(PEI) were used to modify CNTs [29,31,33]. Ahmed et al. 
[31] developed cationic glycopolymer-modified SWNTs for 
in vitro gene transfer agent and found that the complex was 
biocompatible and exhibited transfection efficiencies com-
parable to the commercially available agent, lipofectamine 
2000. Richard et al. [29] reported cationic amphiphiles 
functionalized SWNTs and MWNTs for in vitro gene trans-
fection and showed that the efficiency of transfection was 
higher when using SWNTs instead of MWNTs, and that 
transfection efficiency was similar or slightly higher than 
that using lipoplexes and several orders of magnitude higher 
than that for naked DNA.  
RNA interference (RNAi), a biological process within 
living cells that takes part in the control of gene expression, 
is expected to have great application in gene therapies. Two 
types of small RNA molecules, microRNA (miRNA) and 
short interfering RNA (siRNA), are key players in RNAi. 
Kam et al. [13] first successfully delivered siRNA into 
mammalian cells by linking siRNA to SWNTs via a cleava-
ble disulfide bond. Liu et al. [16] further used this strategy 
to deliver siRNA into human T cells and primary cells, 
which were notoriously “hard-to-transfect” cells by conven-
tional liposome-based agents (Figure 2). Further application 
of siRNA showed that it could also be non-covalently load-
ed onto CNTs. Bartholomeusz et al. [30] reported the use of 
positively-charged SWNTs for non-covalently binding 
siRNA resulting in the in vivo therapeutic silencing of hy-
poxia-inducible factor 1 alpha (HIF-1) in animal experi-
ments.  
Nano-spearing or nano-injection by CNTs is another 
unique approach for controllable gene delivery. In a earlier 
work by Cai et al. [34], DNA plasmids encoding enhanced 
green fluorescence protein (EGFP) were prefunctionalized 
onto CNTs, and these nanotubes were embedded in nickel. 
Using magnetic force, the SWNT needle was speared into a 
specific cell, releasing the DNA plasmid inside cells and 
inducing expression of EGFP. In 2007, Chen et al. [32] re-
ported the development of a nanoscale cell injection system 
that used CNTs to deliver nanoparticle cargo into cells. In 
their experiments, a single MWNT was attached to an atomic 
force microscope (AFM) tip and conjugate to cargo nano-
particles or molecules via disulfide linking. By controlling 
the AFM tip, the “nanoneedle” could penetrate the cell 
membrane. The subsequent reductive cleavage of disulfide 
bonds within the cell cytoplasm resulted in the release of the 
cargo inside cells. This method was successfully used to 
deliver protein-coated quantum dots into live human cells 
without significant cell damage. The above methods provide 
a controllable way to deliver molecules, genes, and nano-
particles into specific cells; however, these methods cannot 
be scaled-up to treat large numbers of cells. 
1.3  Delivery of proteins 
Proteins can be either covalently or non-covalently conjugated  
 
Figure 2  (Color online) siRNA delivery by carbon nanotubes. (a) A 
scheme of SWNT-siRNA conjugation via disulfide linkage. Below: confo-
cal images of untreated cells (left) and SWNT-siRNACXCR4 treated cells 
(right) after PE-anti CXCR4 staining. Scale bars: 40 m. (b) CXCR4 ex-
pression levels on CEM cells three days after various treatments, including 
four types of liposomes (Lipo1–4) and luciferase (Luc) siRNA control 
[16].  
to CNTs for intracellular delivery [12,14]. Kam et al. [12] 
reported in 2004 that CNTs could act as molecular trans-
porters to deliver proteins conjugated to nanotubes into hu-
man promyelocytic leukemia (HL60) cells and human T 
cells (Jurkat) via the endocytosis pathway. In 2005, the 
same group also reported that SWNTs were generic intra-
cellular transporters for various types of proteins [14]. These 
proteins, including streptavidin (SA), protein A (SpA), bo-
vine serum albumin (BSA), and cytochrome c (Cytc), could 
be non-covalently adsorbed onto the nanotube sidewalls by 
non-specific binding via hydrophobic interactions, and then 
shuttled into cells. However, protein delivery with CNTs has 
not yet been demonstrated in animal experiments thus far. 
2  Physical cancer therapies delivered by CNTs 
The unique physical properties of CNTs have been used for 
novel cancer therapies. Both MWNTs and SWNTs exhibit 
strong optical absorption in the NIR, and were used for 
photothermal treatment of cancer. In 2005, Kam et al. [42] 
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reported SWNTs as multifunctional biological transporters 
and near-infrared agents for selective cancer cell destruction 
in vitro. Functionalized SWNTs were able to selectively 
target cancer cells, which were thermally destroyed after 
being exposed to an 808 nm NIR laser at a power density of 
2 W/cm2. Later work by Chakravarty et al. [41] used antibody- 
conjugated SWNTs for in vitro photothermal ablation of 
tumor cells. Kang et al. [38] demonstrated a unique ap-
proach using the photoacoustic effect of SWNTs for target-
ing and selective destruction of cancer cells, where, instead 
of simple heating, a “firecracker”-like explosion was trig-
gered by the pulsed NIR laser to “bomb”cancer cells.  
CNT-based in vivo photothermal therapy of cancer in 
animal models has been reported by in several studies [35– 
37,39,40]. Ghosh et al. [39] demonstrated that DNA-encap-     
sulated MWNTs could be used to safely eradicate tumors 
growing on mice. A MWNT solution (100 L of a 500 μg/mL 
solution) was directly injected to tumors of mice and after 
irradiation with a 1064 nm laser (2.5 W/cm2), PC3 xeno-
graft tumors in 8/8 (100%) of nude mice were completely 
eliminated. Tumors that received only MWNT injection or 
laser irradiation showed growth rates indistinguishable from 
control untreated tumors. SWNTs were also used for in vivo 
photothermal treatment of tumors. Moon et al. [37] showed 
that tumors injected with SWNTs and exposed to the NIR 
laser (76 W/cm3) were completely eliminated, without 
harmful side-effects or recurrence of tumors for over six 
months. Most of the intratumorally-injected SWNTs were 
excreted from mice within two months through biliary and 
urinary pathways.  
In vivo photothermal therapy of tumors has been de-
scribed in animal experiments using CNTs [35,36,40]. Apart 
from direct intratumoral injection, our group has achieved 
photothermal ablation of tumors in mice by well-function-    
alized SWNTs via systemic intravenous injection [36]. Af-
ter a systematical studying the relationship between poly-
mer surface coatings and in vivo behaviors of SWNTs, it 
was found that SWNTs with long blood circulation half-life 
(12–13 h) that showed high passive tumor uptake owing to 
the EPR effect and relatively low accumulations in reticu-
loendothelial systems (RES) and skin, were ideal for in vivo 
photothermal treatment of cancer (Figure 3(a) and (b)). 
Tumors in mice intravenously injected with SWNTs were 
almost completely eliminated after irradiation with the NIR 
laser (808 nm, 1 W/cm2, 5 min) (Figure 3(c) and (d)). Fur-
ther studies described by Robinson et al. [35] showed that  
 
Figure 3  (Color online) SWNTs with the optimized PEG coating for in vivo photothermal therapy of cancer. (a) Scheme of a SWNT with PEGylated am-
phiphilic polymer coating. (b) An AFM image of PEGylated SWNTs. Inset: a solution of SWNTs in saline. (c) Tumor growth curves of different groups 
after treatment. The tumor volumes were normalized to their initial sizes. The P-value between the SWNT + Laser group and untreated control group was 
calculated by student’s t-test. (d) Representative photos of tumors on mice after various treatments indicated. The laser irradiated tumor on a SWNT injected 
mouse was completely destructed. Error bars in (a) were based on SEM. (c) and (d) SWNTs with PEG coating were intravenously injected into seven 
BALB/c mice bearing 4T1 tumors (two tumors per mouse). Another seven control mice were not injected. One tumor of each mouse was exposed to an 808 
nm laser at the power of 1 W/cm2 while the other tumor was not irradiated [36]. 
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SWNTs could be used for combined high performance in 
vivo NIR (>1 m) fluorescence imaging and photothermal 
therapy, highlighting the promise of utilizing SWNTs for 
highly effective in vivo imaging-guided photothermal ther-
apy of cancers. More interestingly, the NIR laser power 
applied was only 0.6 W/cm2, which was much lower than 
that needed for other light-absorbing nanomaterials used in 
the photothermal therapy of cancer. 
The major disadvantage of phototherapies is the limited 
light penetration depth in biological tissues, even when NIR 
light is used. In 2007, Gannon et al. [43] reported that func-
tionalized, water-soluble SWNTs exposed to a noninvasive, 
13.56 MHz radio frequency (RF) field could generate heat. 
They further utilized this property of SWNTs for RF-induced 
thermal destruction of cancer cells in vitro and in vivo. This 
is significant since RF waves have excellent tissue penetra-
tion that allows the heating of large or internal tumors. 
3  Biosensing 
As 1-D quantum wires with a sharp electronic density of 
states at the van Hove singularities, SWNTs exhibit many 
unique intrinsic properties, including semiconducting be-
haviors and band gap fluorescence for nanotubes with cer-
tain chiralities, as well as strong resonance Raman scatter-
ing, making them excellent candidates as novel nano-probes 
in biosensors [7]. Tailoring hybrid systems consisting of 
CNTs and biomolecules has been rapidly expanded recently 
and are still attracting substantial research efforts [18,19]. 
3.1  Optical sensors 
The band-gap fluorescence of SWNTs is highly sensitive to 
the environment and undergoes shifts when the nanotube 
surface is in contact with other molecules. In 2004, Barone 
et al. [78] reported the synthesis and successful testing of 
solution-phase, NIR SWNTs optical sensor for -D-glucose 
sensing as a model system. In their experiments, non-cova-    
lent functionalized SWNTs suspended using glucose oxi-
dase (GOx) in solution was first prepared. Electroactive 
species, such as potassium ferricyanide, K3Fe(CN)6, could 
irreversibly adsorb to the surface and quenched the SWNT 
fluorescence emission. Hydrogen peroxide (one of the target 
analytes) could then reduce ferricyanide, resulting in the 
restoration of both absorption and emission features of 
SWNTs. The synthesized optical sensor was sensitive in the 
general range of blood glucose levels with a detection limit 
of 34.7 mol/L. In vivo fluorescence detection of blood 
glucose by implanting the SWNT-based sensor beneath the 
skin was further proposed by this team in their later work 
[48]. 
Heller et al. [20] successfully detected the conforma-    
tional polymorphism of DNA using SWNT-based optical 
sensors. Certain DNA oligonucleotides will transform from 
the native, right-handed B-form to the left-handed Z-form as 
the adsorption of some cations (for example, Hg2+ and Co2+) 
onto the double-stranded DNA and screen the negatively- 
charged backbone. The dielectric environment of SWNT 
changed as the conformation of a 30-nucleotide dsDNA 
adsorbed onto SWNTs changed from an analogous B- to 
Z-form, decreasing the SWNT NIR emission energy up to 
15 meV. The thermodynamics of the conformational change 
for DNA both on and off the SWNT are nearly identical. 
With this mechanism, they demonstrated the detection of 
the B-Z transition in whole blood, tissue, and from within 
living mammalian cells. Many other SWNT-based NIR flu-
orescence biosensors developed by different teams have 
also found their application for the detection of single nu-
cleotide polymorphisms [47], fluorescent detection of cel-
lular ATP [45], single-molecule H2O2 signaling from epi-
dermal growth factor receptor (EGFR) [46], and nitric oxide 
[44]. 
The Raman scattering property of SWNTs can also be 
used in biosensing. In a study by Chen et al. [49] the strong 
resonance Raman scattering of SWNTs was further en-
hanced by the gold substrate via surface enhanced Raman 
scattering (SERS), for ultra-sensitive detection of biomole-
cules (Figure 4(a) and (b)). PEGylated SWNTs with differ-
ent isotopic compositions (12C and 13C) were conjugated to 
antibodies and used as multicolor Raman labels for multi-
plexed protein detection in an arrayed format. The detection 
limit achieved in this study was down to 1 fmol/L, a three- 
order-of-magnitude improvement over most reports using 
fluorescence-based detection (Figure 4(c) and (d)). 
3.2  Electronic and electrochemical sensors 
The molecules that bind to the surface of nanotubes are able 
to act as the “gating molecules” to modulate the conduct-
ance of semi-conducting SWNTs in a field effect transistor 
(FET) device. This property is used in various SWNT-based 
electronic biosensors [79]. 
Kong et al. [55] presented one of the first SWNT-based 
chemical sensors. Because of the sensitivity increase or de-
crease of the electrical resistance of SWNTs when exposed 
to gaseous molecules such as NH3 and NO2, the lowest de-
tectable limit was down to concentrations as low as 1 ppm. 
Similar to SWNTs, aligned multi-wall carbon nanotubes 
(MWNT) grown on a platinum substrate were also devel-
oped into an amperometric biosensor [80]. The first CNT- 
FET showing real-time biological and pH sensing capabili-
ties was reported by Besteman et al. [54] in 2003 where the 
changes in nanotube conductance were measured and then 
transformed the data to the glucose oxidase activity.  
Chen et al. [53] first overcame the problem of nonspeci-    
fic binding of proteins on nanotubes, by the immobilization 
of PEG chains on the sidewall surface of SWNTs. The se-
lective detection of proteins in solution is highly sensitive, 
as the limit of detection was found to be 340 ng/mL  
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Figure 4  (Color online) SWNT-antibody conjugates may be utilized in conjunction with surface-enhanced Raman scattering (SERS) as bright Raman tags 
for sandwich assay protein detection. (a) Preparation of a spatially uniform SERS substrate for SWNT Raman tag detection of biomolecules significantly 
increases Raman scattering intensity, thus improving signal-to-noise and reducing assay time. (b) SWNT-antibody conjugates were formulated by first sus-
pending SWNTs in aqueous media via PEGylated surfactants, which provide functionality and prevent non-specific interactions to the hydrophobic SWNT 
surface, and subsequently coupled to antibodies via bifunctional cross-linkers. Such antibody-Raman tags have been used in direct and indirect immunoas-
says. (c) SWNT-anti-mouse IgG conjugates were applied to direct detection of mouse IgGs, demonstrating excellent signal-to-noise and minimal cross- 
reactivity. (d) SWNT-anti-mouse IgG conjugates were used as Raman tags for the indirect detection of mouse anti-human serum albumin (aHSA) IgG cap-
tured onto a SERS active substrate by HSA. A limit of detection of 1 fmol/L analyte was reproducibly observed (two separate trials are shown). The data are 
well fit by a logistic regression (solid red curve, fit to data shown in green) allowing accurate quantitation of analyte over eight orders of magnitude [49].  
(approximately 2.3 nmol/L). Ultrasensitive electrical biosens-    
ing of proteins and DNA based on carbon nanotubes were 
achieved by Wang et al. [52] in 2004. The sandwich hy-
bridization technique dramatically enhances the sensitivity 
of these assays, and shows a remarkably low detection limit of 
around 1 fg/mL (54 amol/L). Except for proteins and enzymes, 
the first SWNT-FET-based biosensor comprising DNA ap-
tamers as the molecular recognition elements was reported 
by So et al. [51] in 2005. Maehashi et al. [81] developed 
label-free protein biosensors also based on aptamer-modified 
CNT-FETs for the detection of immunoglobulin E (IgE).  
In addition to the single-mode biosensors, Oh et al. [50] 
reported a carbon nanotube based dual-mode biosensor for 
electrical and surface plasmon resonance (SPR) measure-
ment. When DNA hybridization occurred on the Au top 
gate, it could be detected immediately by the change in 
electrical conductance and surface plasmon resonance (SPR). 
Using this kind of dual-mode measurement, the sensor-to- 
sensor variation of conductance measurements could be 
minimized by calibration using SPR data. 
Electrochemical detection offers several advantages over 
conventional fluorescence measurements, such as portability, 
higher performance with lower background, less-expensive 
components, and the ability to perform measurements in 
turbid samples [56]. CNT-based electrochemical biosensors 
for the detection of diverse biological structures such as 
DNA, viruses, antigens, and disease markers have been re-
cently reported by many groups [56,57,82]. The key to us-
ing CNTs for these applications is their ability to promote 
electron transfer in electrochemical reactions [59,83]. 
An emerging trend is the sensing of whole cells (for ex-
ample, neural biosensing), and interactions between differ-
ent cells using CNTs [58,61,84]. Keefer et al. [60] investi-
gated the use of nanotube-coated electrodes in preparing 
brain-machine interfaces. The carbon nanotube coating on 
the electrodes were biocompatible and enhanced both re-
cording and electrical stimulation of neurons in vitro in cell 
culture, as well as in vivo in rats and monkeys, by decreas-
ing the electrode impedance and increasing charge transfer. 
Lin et al. [85] reported an electrochemical sensor devised 
for the continuous and simultaneous monitoring of glucose 
and lactate in rat brain tissue. This study included a com-
plex electroanalytical system in which SWNTs were loaded 
with glucose dehydrogenase or lactate dehydrogenase were 
prepared for real-time monitoring of the metabolic intermedi-
ate, glucose, or the circulatory impairment molecule, lactate.  
4  Biomedical imaging 
CNTs have also been widely used in a variety of biomedical 
imaging modalities, including optical imaging [7,22,42,66, 
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68,69], magnetic resonance imaging [86–88], and nuclear 
imaging [89] (Figure 5); the latter two mainly rely on the 
external labels or impurities in the CNT samples for imag-
ing contrast. Here, we will focus on the utilization of the 
inherent physical properties of SWNTs for optical imaging 
in biological systems. 
4.1  NIR fluorescence imaging 
Semi-conducting SWNTs exhibit bad-gap photolumines-
cence when excited by the NIR light and have been used in 
fluorescence imaging of biological samples. Cherukuri et al. 
[65] found that macrophage cells could actively take up 
significant quantities of SWNTs by detecting NIR fluores-
cence signals (>1100 nm) from nanotubes inside macro-
phage cells. Subsequently, the first report of in vivo NIR 
imaging of SWNTs in drosophila larvae was achieved by 
Leeuw et al. [63] in 2007.  
Welsher et al. [22] reported the use of SWNTs as NIR 
fluorescent tags for selective probing and imaging of cells. 
In this study, they first conjugated Rituxan (anti-CD20 an-
tibody) onto biocompatible SWNTs, and incubated these 
with two types of cells: Raji B-cell lymphoma (CD20+) and 
CEM T-cell lymphoma (CD20–). Strong NIR photolumines-
cence of SWNTs could be detected from the positive Raji 
cells after labeling with the nanotube-antibody conjugate.  
Low quantum yield (QY) is a major limitation for SWNT- 
based fluorescence imaging [64] . It has been found that the 
photoluminescence QY is closely related to the length and 
surface coating of nanotubes. Although PEGylated SWNTs  
 
Figure 5  SWNT based in vivo cancer imaging. (a) A scheme of PEGylated SWNT conjugated to RGD peptide and DOTA-64Cu, for tumor targeting and 
radiolabeling, respectively. (b) Integrin v3 targeted in vivo tumor imaging by whole mouse micro-PET imaging, tumor local photoacoustic imaging and 
Raman imaging. Nude mice bearing U87MG tumors (integrin v3 positive) were intravenously injected with either plain SWNTs or SWNT-RGD. (c) In-
travital high resolution photoluminescence imaging of tumor vasculature using SWNTs as the contrast agent [62,67,69,89].  
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exhibit excellent biocompatibility, their QY was signifi-
cantly lower than that of surfactant-suspended nanotubes, 
the latter however were not biocompatible and thus not 
suitable for applications in bio-imaging. In 2009, Welsher et 
al. [62] revealed that the surface coating of SWNTs pre- 
sonicated in sodium cholate could be replaced by PEGylat-
ed phospholipid (PL-PEG) to gain biocompatibility with 
retained high QY. It was reported that the QY of the ex-
changed-SWNTs prepared by this method was more than 
one order of magnitude enhanced over SWNTs directly 
suspended in PL-PEG. These exchange-SWNT conjugates 
were then used as contrast agents for in vitro and in vivo 
NIR imaging with outstanding performance (Figure 6(c)). 
More recently, Hong et al. [90] observed the first metal- 
enhanced fluorescence of SWNTs. In their experiments, 
SWNTs modified by gold showed enhanced fluorescence 
resulting from radioactive lifetime shortening by >10-fold 
through resonance coupling of SWNT emission to plas-
monic modes in the metal. A latest study by the same labo-    
ratory further showed that the Au substrate could be used 
for NIR-fluorescence-enhanced (NIR-FE) cellular imaging 
by using both SWNTs and organic fluorescent labels [91]. 
The noble metal nanostructure-enhanced SWNT photolu-
minescence provides a novel approach for improved sensi-
tivity in SWNT-based fluorescence imaging and detection. 
4.2  Raman imaging 
Raman spectroscopy is a very important and noninvasive 
tool to analyze vibration in molecules. Raman imaging of 
SWNTs in live cells was first reported by Heller et al. [92] 
in 2005. DNA functionalized SWNTs were incubated with 
3T3 fibroblast and myoblast stem cells and Raman spectro-
scopic mapping was conducted under 785 nm laser excita-
tion, showing high SWNT Raman signals inside cells. It 
was found that the photostability of SWNTs was many or-
ders of magnitudes better than that of organic fluorescent 
dyes and NIR quantum dots. 
Targeted in vivo Raman imaging was conducted by 
Zavaleta et al. [67]. In their experiment, mice bearing U87MG  
 
Figure 6  (Color online) Mutli-color Raman imaging with isotopically modified SWNTs. (a) A scheme showing isotopically modified SWNTs conjugated 
with different targeting ligands. Color1, 2, 3, 4, and 5 represent SWNTs with 13C percentages of 100%, 65%, 50%, 25%, and 0%, respectively. (b) Raman 
spectra of the five different SWNT samples in aqueous solutions. The shift of SWNT Raman G-band peak is clearly dependent on the 12C/13C ratio in 
SWNTs. (c) Five-color Raman imaging of cancer cells. (d) Five-color Raman images of a LS174T human colon tumor slice from a mouse model. Separate 
images represent five protein expression levels [21,66].  
176 Wang X J, et al.   Chin Sci Bull   January (2012) Vol.57 No.2-3 
tumors were intravenously injected with PEGylated SWNTs 
conjugated with a RGD peptide to target integrin v3 up-
regulated on tumor vasculature and tumor cells. Strong SWNT 
Raman signals were detected from tumors receiving target-
ing SWNTs but not plain SWNTs without RGD conjugation 
(Figure 6(b)).  
SWNTs with different isotope compositions show shifted 
G-band peaks [93], thus can be used as different colors for 
Raman imaging under a single laser excitation. Multiplexed 
three-color imaging of tumor cells and tissues with CNTs 
was achieved by Liu et al. [21]. Pure 12C, pure 13C and 
mixed 12C/13C SWNTs with different Raman G-band peaks 
at positions of 1590, 1528, and 1544 cm1, respectively, 
were used as three different Raman “colors” for multiplexed 
Raman imaging. By varying 12C/13C ratios during nanotube 
synthesis, as many as five SWNT Raman “colors” were 
obtained in in subsequent studies by the same group [66] 
(Figure 6). 
Compared with fluorescence dyes, Raman spectroscopy 
of SWNTs are resistant to autofluorescence and photo-
bleaching, but its inherently weak effect has limited its ap-
plication to some extent. The full width at half-maximum 
(FWHM) of the SWNT G peak is very narrow, allowing for 
high degrees of multiplicity [21,66]. In the Raman imaging, 
excitation (785 nm) and scattered photons (892–897 nm) are 
all in the NIR window which allows excellent tissue absorp-
tion [8] and low autofluorescence background.  
4.3  Photoacoustic imaging 
Photoacoustic imaging of living subjects allows deeper tis-
sue penetration compared with most optical imaging tech-
niques [38,68,69]. CNTs with strong light absorption in the 
NIR absorb optical energy from a pulsed laser and turn it 
into acoustic waves, and thus can serve as photoacoustic con-
trast agents. De la Zerda et al. [69] showed that PEGylated 
SWNTs conjugated with RGD were also useful for targeted 
in vivo tumor photoacoustic imaging in mice (Figure 6(b)). 
An improved SWNT-based photoacoustic imaging contrast 
agent was reported by the same laboratory [68]. In this work, 
indocyanine green dye-SWNTs (SWNT-ICG) gave a 300-fold 
higher photoacoustic contrast compared with plain SWNTs, 
while the size and targeting ability of the nanotube contrast 
agent did not significantly vary. 
5  Scaffold in tissue engineering 
Tissue engineering focuses on the improvement, repair, or 
replacement of tissues and organs [94]. CNTs are becoming 
increasingly attractive tissue engineering materials as they 
can be modified to be integrated into biological systems 
with excellent biocompatibility [23]. In addition to high 
aspect ratios, CNTs also show many intrinsic mechanical, 
electrical, and physical properties useful for applications in 
tissue scaffolds [24,95–97]. 
5.1  CNTs used as scaffolds in bone regeneration 
In 2006, Zanello et al. [73] found the use of CNTs as scaf-
fold materials for osteoblast proliferation and bone for-
mation, and demonstrated that CNTs were suitable to pro-
mote osteoblast functions. After incubating cells with CNTs, 
there was a dramatic change in cell morphology of osteo-
blasts, which correlated with changes in plasma membrane 
functions. 
Three-dimensional (3D) tubular MWNT composite (for 
example, PLGA/MWNT ) could also serve as scaffolds for 
tissue engineering [71]. The tubular knitted scaffold was 
prepared from a MWNT yarn by electrospinning poly(lactic- 
co-glycolic acid) (PLGA)/MWNT nanofibers onto the knit-
ted scaffold. It was shown that not only could the scaffold 
support cell growth throughout the culture period, but also 
had the potential to utilize the intrinsic electrical and me-
chanical properties of carbon nanotubes for various special 
applications. Biocompatible MWNT/chitosan (CHI) scaf-
folds were also developed, showing remarkable perfor-
mance in both in vitro and in vivo experiments [72]. The 
adsorption properties of MWNT were used for incorpora-
tion of recombinant human bone morphogenetic protein-2 
(rhBMP-2) to promote the ectopic bone formation at muscle 
tissue. The biocompatibility of the MWNT/CHI scaffold was 
high since no chronic inflammation occurred throughout the 
implantation period. Bone tissue regeneration was indeed 
observed three weeks after the implantation. In vivo exper-
iments also showed that most of the MWNT/CHI migrated 
out from the implant zone, and was possibly gradually 
cleared from the body. 
Another CNT-based composite containing poly(3-hy-     
droxybutyrate) (P(3HB)) was able to serve as 3D porous 
scaffolds with multifunctionality for bone tissue engineering 
was reported by Misra et al. [70]. The microstructure, cyto-
compatibility, biocompatibility, bactericidal ability, and 
multifunctionality of the composite were studied systemati-
cally (Figure 7). Each additive of the scaffold composite 
was able to contribute to the overall performance, i.e. bio-
glass particles imparting bioactivity, vitamin E improving 
protein adsorption, and finally MWNT inducing electrical 
conductivity. This work presents the concept of “multifunc-
tional scaffolds”, which paves the way for next generation 
of advanced scaffolds for bone tissue engineering. These 
previous studies demonstrate that CNTs and their composite 
materials can serve as osteogenic scaffolds with good bio-
compatibility, reinforced mechanical properties, and im-
proved electrical conductivity to effectively enhance bone 
tissue growth.  
5.2  CNTs for neural applications 
CNTs can also be utilized in the neuron axon regeneration  
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Figure 7  (Color online) An example of the CNT-based tissue engineer-
ing scaffold. (a) Cell proliferation study using Alamar blue assay for P(3HB) 
and P(3HB)/m- BG composite scaffolds on day 1 and 4. SEM micrographs 
of MG-63 cells grown for 4 days on (b) P(3HB) foams (arrow marks the 
MG-63 cell layer), (c) P(3HB)/m-BG foams, (d) P(3HB) foams highlighting 
the spread of the cells and bridging the pores (image enhanced by artificial 
colors) and, (e) P(3HB)/m-BG foams demonstrating the ability of the cells 
to bridge the pores and also to take up the contours of the substrate [70].  
as biomimetic scaffolds. Hu et al. [61] used chemically 
functionalized CNTs as substrates for neuronal growth. 
Their results revealed that MWNTs with different surface 
charges resulted in different neurite outgrowth patterns. 
Compared with negatively charged MWNTs, positively 
charged MWNTs significantly increased the number of 
growth cones and neurite branches. Lovat et al. [75] report-
ed the potentially boosted electrical signal transfer of neu-
ronal networks by purified MWNTs where it was found that 
MWNTs were able to improve neural signal transfer while 
supporting neuron axon regeneration. 
Neural stem cells (NSCs) are very plastic neural precur-
sors and quite sensitive to environmental changes. Jan et al. 
[74] first demonstrated that mouse embryonic NSCs from 
the cortex could be successfully differentiated to neurons, 
astrocytes, and oligodendrocytes with clear formation of 
neurites on layer-by-layer assembled SWNT-composite. 
Biocompatibility, neurite outgrowth, and expression of 
neural markers were similar to those differentiated on poly- 
L-ornithine (PLO), one of the most widely used growth 
substrates for neural stem cells. The unique properties of 
CNTs rendered the SWNT composites high electrical con-
ductivity, chemical stability, and physical strength with 
structural flexibility and showed no adverse affect on the 
differentiation of NSCs . 
6  Conclusion 
This review article summarizes the research of CNTs in a 
variety of biomedical applications, including drug delivery, 
cancer therapies, biosensing, bio-imaging, and tissue engi-
neering. Recent years have witnessed the booming devel-
opment of CNTs and their composites in biological and 
medicine. Although the future perspective of CNT-based 
nanomedicine is fascinating and encouraging, whether 
CNTs will bring a biomaterial revolution remains unknown. 
For applications that require the administration of CNTs 
into animals and hopefully finally into humans, the major 
challenge is the potential long-term toxicity of CNTs. It has 
been shown by many groups that the toxicology of CNTs is 
determined by the administration routes, doses, as well as 
the surface chemistry and sizes of nanotubes, and well- 
functionalized CNTs are not apparently toxic in vitro to 
cells and in vivo to mice at their tested doses [7,36,98–103]. 
However, many more studies are still required to optimize 
the surface chemistry and sizes of CNTs for accelerated 
excretion from biological systems, as nanotubes are not 
considered to be biodegradable. How CNTs affect the im-
mune, nervous, and reproductive systems, especially in the 
long-term, are still not fully understood. On the other hand, 
for ex vivo detection in which the toxicology of CNTs is not 
a concern, reproducibility in the fabrication process may be 
a problem for CNT-based biosensors. Compared with other 
biosensors, how prominent the advantages of using CNTs- 
based biosensors needs to be further explored. Despite the 
obstacles towards further applications of CNTs in the clinic, 
the unique structure, size, shape, as well as highly enriched 
physical and chemical properties of CNTs make them ex-
tremely attractive nanomaterials and may enable novel ap-
plications in a variety of areas of biomedicine. 
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